Stock Under $10 with 50-100% upside potential - 14 Days FREE!

CCS Medical Announces Agreement With LifeScan

FARMERS BRANCH, Texas, March 6, 2013 /PRNewswire/ -- CCS Medical announced today that is has entered into an agreement with LifeScan, Inc., to provide diabetes testing supplies to patients across the country. 

(Logo: http://photos.prnewswire.com/prnh/20130306/FL72774LOGO )

"This agreement means that CCS Medical is a LifeScan Direct Mail Order Supplier with the ability to serve all Medicare beneficiaries and many commercial plan members who use LifeScan products, such as LifeScan's OneTouch® Ultra® meter and test strips," said Dirk Allison, CCS Medical President and Chief Executive Officer. 

"This is a tremendous development for CCS Medical that will enhance our leadership role within the industry," said Allison.  "We are excited about our renewed partnership with an industry leader such as LifeScan, which serves to further validate our mission of providing high-quality products to our patients at a low price."  

About CCS Medical  Established in 1994, CCS Medical is a rapidly growing provider of low-cost, high-quality products and services delivered directly to homes of patients with chronic conditions.  The company offers a single source solution for diabetes testing supplies, insulin pumps, catheters, ostomy supplies, advanced wound care dressings, incontinence supplies, and prescription medications.  CCS Medical's patient-centered model specializes in convenient home delivery, product education, and insurance processing.  CCS Medical is a privately held company and its largest shareholders are funds managed by Highland Capital Management, L.P.  More information is available at www.ccsmed.com.

 

SOURCE CCS Medical

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,375.90 21.50 0.14%
NASDAQ 3,509.03 10.06 0.29%
S&P 500 1,672.66 5.19 0.31%
US 10 Yr 1.970% +0.021

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs